Biogen - 27 Year Stock Price History | BIIB

Historical daily share price chart and data for Biogen since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Biogen as of December 17, 2018 is 313.10.
Biogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 314.4704 334.1700 383.8300 257.5200 313.1000 -1.72%
2017 289.1924 268.8803 344.5800 246.5400 318.5700 21.88%
2016 258.2701 271.5625 304.2750 207.0224 261.3865 -7.43%
2015 324.9891 315.2437 438.7290 236.0019 282.3745 -9.75%
2014 293.0971 258.3909 332.4433 252.1115 312.8840 21.42%
2013 198.4327 138.2607 272.7239 131.6427 257.6922 91.00%
2012 125.8311 104.6173 143.8465 104.6173 134.9148 33.00%
2011 84.7777 61.9408 109.4288 59.9867 101.4373 64.13%
2010 51.9472 49.4420 62.8810 42.6027 61.8025 25.33%
2009 45.1133 44.6951 49.4973 38.8328 49.3130 12.32%
2008 51.0893 51.4975 65.7937 35.9662 43.9024 -16.32%
2007 52.1588 45.4693 76.0526 39.7546 52.4653 15.71%
2006 42.3905 43.0820 48.1700 37.5424 45.3403 8.64%
2005 39.8850 61.1020 62.4939 30.7400 41.7363 -32.02%
2004 52.7677 34.0490 62.6045 34.0490 61.3970 81.50%
2003 31.7365 31.6525 38.3167 25.8916 33.8278 10.64%
2002 43.7536 62.8165 65.4065 27.7904 30.5741 -51.88%
2001 52.5351 54.6130 68.7340 32.8968 63.5354 9.09%
2000 40.8053 28.6507 69.2072 17.6298 58.2416 92.94%
1999 12.9850 7.1819 30.1869 6.3185 30.1869 318.08%
1998 5.0456 5.2032 7.3923 2.6884 7.2203 36.71%
1997 4.3215 3.4565 7.0667 2.4964 5.2816 44.76%
1996 3.4365 2.9373 4.6271 2.2460 3.6485 21.80%
1995 1.0523 0.3641 3.5533 0.3457 2.9956 815.53%
1994 0.5396 0.8634 0.9985 0.3272 0.3272 -62.96%
1993 0.8822 1.3826 1.3826 0.5761 0.8833 -34.29%
1992 1.5007 1.9587 3.0725 0.9601 1.3442 -32.69%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $63.084B $12.274B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.123B 13.69
Gilead Sciences (GILD) United States $84.241B 10.14
Celgene (CELG) United States $47.640B 9.24
Illumina (ILMN) United States $45.701B 53.24
Vertex Pharmaceuticals (VRTX) United States $42.466B 74.18
Regeneron Pharmaceuticals (REGN) United States $40.632B 20.59
Alexion Pharmaceuticals (ALXN) United States $24.436B 16.72
BioMarin Pharmaceutical (BMRN) United States $16.462B 0.00
Incyte (INCY) United States $13.794B 381.29
Seattle Genetics (SGEN) United States $9.389B 0.00
Exact Sciences (EXAS) United States $8.248B 0.00
BeiGene (BGNE) Cayman Islands $7.928B 0.00
QIAGEN (QGEN) Netherlands $7.776B 24.87
Sarepta Therapeutics (SRPT) United States $7.731B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.507B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.426B 47.48
Exelixis (EXEL) United States $6.231B 17.66
Bluebird Bio (BLUE) United States $5.719B 0.00
Bio-Techne Corp (TECH) United States $5.544B 37.45
Galapagos (GLPG) Belgium $5.215B 0.00
Alkermes (ALKS) Ireland $5.120B 3295.00
Amarin (AMRN) Ireland $5.021B 0.00
Immunomedics (IMMU) United States $3.401B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.381B 0.00
Horizon Pharma Public (HZNP) Ireland $3.353B 13.79
Array BioPharma (ARRY) United States $3.313B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.277B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.120B 0.00
Guardant Health (GH) United States $3.108B 0.00
Emergent Biosolutions (EBS) United States $3.101B 26.12
Allogene Therapeutics (ALLO) United States $3.088B 0.00
Ligand Pharmaceuticals (LGND) United States $2.815B 21.54
Akcea Therapeutics (AKCA) United States $2.716B 0.00
Ascendis Pharma (ASND) Denmark $2.675B 0.00
Blueprint Medicines (BPMC) United States $2.444B 0.00
China Biologic Products (CBPO) China $2.410B 17.15
Allakos (ALLK) United States $2.386B 0.00
Genomic Health (GHDX) United States $2.383B 80.45
Repligen (RGEN) United States $2.378B 74.26
Myriad Genetics (MYGN) United States $2.321B 23.00
Ultragenyx Pharmaceutical (RARE) United States $2.247B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.196B 0.00
Global Blood Therapeutics (GBT) United States $2.171B 0.00
Halozyme Therapeutics (HALO) United States $2.168B 48.39
MyoKardia (MYOK) United States $2.056B 0.00
Acceleron Pharma (XLRN) United States $2.003B 0.00
Amicus Therapeutics (FOLD) United States $1.986B 0.00
Arena Pharmaceuticals (ARNA) United States $1.894B 0.00
Denali Therapeutics (DNLI) United States $1.871B 0.00
Atara Biotherapeutics (ATRA) United States $1.805B 0.00
AnaptysBio (ANAB) United States $1.749B 0.00
Reata Pharmaceuticals (RETA) United States $1.692B 0.00
Innoviva (INVA) United States $1.679B 9.50
REGENXBIO (RGNX) United States $1.642B 22.02
CRISPR Therapeutics AG (CRSP) Switzerland $1.639B 0.00
Spark Therapeutics (ONCE) United States $1.523B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.503B 0.00
Rubius Therapeutics (RUBY) United States $1.394B 0.00
WAVE Life Sciences (WVE) Singapore $1.372B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.352B 107.38
Cambrex (CBM) United States $1.348B 10.07
Medicines (MDCO) United States $1.330B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.327B 0.00
Editas Medicine (EDIT) United States $1.321B 0.00
Aimmune Therapeutics (AIMT) United States $1.297B 0.00
Mirati Therapeutics (MRTX) United States $1.292B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.216B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.202B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.186B 0.00
Myovant Sciences (MYOV) United Kingdom $1.184B 0.00
NeoGenomics (NEO) United States $1.174B 96.61
Sangamo Therapeutics (SGMO) United States $1.165B 0.00
Lion Biotechnologies (IOVA) United States $1.139B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.097B 0.00
Insmed (INSM) United States $1.078B 0.00
G1 THERAPEUTICS (GTHX) United States $1.052B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.008B 0.00
UniQure (QURE) Netherlands $1.007B 0.00
Clovis Oncology (CLVS) United States $0.995B 0.00
Fate Therapeutics (FATE) United States $0.974B 0.00
Retrophin (RTRX) United States $0.961B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.956B 0.00
Apellis Pharmaceuticals (APLS) United States $0.954B 0.00
Audentes Therapeutics (BOLD) United States $0.951B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.932B 0.00
Novavax (NVAX) United States $0.869B 0.00
DBV Technologies (DBVT) France $0.842B 0.00
Puma Biotechnology (PBYI) United States $0.817B 0.00
Solid Biosciences (SLDB) United States $0.796B 0.00
Athenex (ATNX) United States $0.790B 0.00
Acorda Therapeutics (ACOR) United States $0.777B 9.84
Lexicon Pharmaceuticals (LXRX) United States $0.773B 0.00
AC Immune SA (ACIU) Switzerland $0.743B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.741B 0.00
Vericel (VCEL) United States $0.741B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.740B 0.00
Cellectis (CLLS) France $0.737B 0.00
Revance Therapeutics (RVNC) United States $0.710B 0.00
Heska (HSKA) United States $0.710B 58.11
Aptinyx (APTX) United States $0.710B 0.00
Intra-Cellular Therapies (ITCI) United States $0.704B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.700B 0.00
Principia Biopharma (PRNB) United States $0.692B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.686B 0.00
Intellia Therapeutics (NTLA) United States $0.663B 0.00
Coherus BioSciences (CHRS) United States $0.658B 0.00
CytomX Therapeutics (CTMX) United States $0.655B 0.00
UNITY Biotechnology (UBX) $0.639B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.638B 0.00
Dynavax Technologies (DVAX) United States $0.636B 0.00
UROGEN PHARMA (URGN) Israel $0.629B 0.00
Viking Therapeutics (VKTX) United States $0.622B 0.00
ANI Pharmaceuticals (ANIP) United States $0.604B 11.56
Scholar Rock Holding (SRRK) United States $0.602B 0.00
Gritstone Oncology (GRTS) United States $0.598B 0.00
Eidos Therapeutics (EIDX) United States $0.584B 0.00
InflaRx (IFRX) Germany $0.568B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.568B 0.00
Cara Therapeutics (CARA) United States $0.549B 0.00
RA PHARMCTL INC (RARX) United States $0.536B 0.00
TWIST BIOSCIENC (TWST) United States $0.536B 0.00
Arcus Biosciences (RCUS) United States $0.525B 0.00
AVROBIO (AVRO) United States $0.521B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.519B 0.00
Kura Oncology (KURA) United States $0.502B 0.00
Arvinas (ARVN) United States $0.498B 0.00
ObsEva SA (OBSV) Switzerland $0.477B 0.00
Replimune (REPL) United States $0.473B 0.00
Epizyme (EPZM) United States $0.470B 0.00
BeyondSpring (BYSI) United States $0.455B 0.00
Anika Therapeutics (ANIK) United States $0.454B 18.78
Inovio Pharmaceuticals (INO) United States $0.450B 0.00
Prothena (PRTA) Ireland $0.438B 0.00
Osiris Therapeutics (OSIR) United States $0.434B 0.00
Kezar Life Sciences (KZR) United States $0.434B 0.00
PDL BioPharma (PDLI) United States $0.420B 6.86
Adaptimmune Therapeutics (ADAP) United Kingdom $0.415B 0.00
Senesco Technologies (ELOX) United States $0.409B 0.00
Zymeworks (ZYME) Canada $0.408B 0.00
Sinovac Biotech (SVA) China $0.397B 0.00
Cytokineticsorporated (CYTK) United States $0.397B 0.00
Zealand Pharma (ZEAL) Denmark $0.388B 4.27
Kindred Biosciences (KIN) United States $0.384B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.379B 0.00
MediciNova (MNOV) United States $0.377B 0.00
Mesoblast (MESO) Australia $0.377B 0.00
Evelo Biosciences (EVLO) United States $0.372B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.366B 0.00
Abeona Therapeutics (ABEO) United States $0.350B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Stemline Therapeutics (STML) United States $0.342B 0.00
Krystal Biotech (KRYS) United States $0.339B 0.00
Five Prime Therapeutics (FPRX) United States $0.334B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.333B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.325B 0.00
Liquidia Technologies (LQDA) United States $0.317B 0.00
ResTORbio (TORC) United States $0.304B 0.00
Sorrento Therapeutics (SRNE) United States $0.302B 49.40
MeiraGTx Holdings (MGTX) United States $0.300B 0.00
Albireo Pharma (ALBO) United States $0.285B 0.00
Verastem (VSTM) United States $0.285B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.284B 0.00
Merus (MRUS) Netherlands $0.278B 0.00
Kadmon Holdings (KDMN) United States $0.272B 0.00
MannKind (MNKD) United States $0.271B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Agenus (AGEN) United States $0.265B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
Intec Pharma (NTEC) Israel $0.252B 0.00
Kodiak Sciences (KOD) United States $0.245B 0.00
Arbutus Biopharma (ABUS) Canada $0.245B 0.00
Athersys (ATHX) United States $0.244B 0.00
BioDelivery Sciences (BDSI) United States $0.243B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.242B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.239B 0.00
Syros Pharmaceuticals (SYRS) United States $0.239B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Magenta Therapeutics (MGTA) United States $0.223B 0.00
Geron (GERN) United States $0.222B 0.00
PSivida (EYPT) United States $0.219B 0.00
Adverum Biotechnologies (ADVM) United States $0.217B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.213B 0.00
Celcuity (CELC) United States $0.212B 0.00
Celyad SA (CYAD) Belgium $0.210B 0.00
Aduro Biotech (ADRO) United States $0.209B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
LogicBio Therapeutics (LOGC) United States $0.194B 0.00
Kamada (KMDA) Israel $0.192B 17.70
Synlogic (SYBX) United States $0.189B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
Equillium (EQ) United States $0.187B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
TOCAGEN INC (TOCA) United States $0.175B 0.00
Kala Pharmaceuticals (KALA) United States $0.169B 0.00
Urovant Sciences (UROV) United States $0.167B 0.00
Protagonist Therapeutics (PTGX) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
Proteostasis Therapeutics (PTI) United States $0.164B 0.00
XBiotech (XBIT) United States $0.163B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.159B 0.00
ChromaDex (CDXC) United States $0.158B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
Unum Therapeutics (UMRX) United States $0.153B 0.00
Cohbar (CWBR) United States $0.152B 0.00
Constellation Pharmaceuticals (CNST) United States $0.152B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.148B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.147B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.144B 0.00
Palatin Technologies (PTN) United States $0.143B 17.58
Axovant Sciences (AXON) United Kingdom $0.141B 0.00
Enzo Biochem (ENZ) United States $0.135B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.134B 0.00
CorMedix Inc (CRMD) United States $0.134B 0.00
Cerecor (CERC) United States $0.133B 0.00
BioTime (BTX) United States $0.133B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.132B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.119B 0.00
XOMA (XOMA) United States $0.119B 0.00
Organovo Holdings (ONVO) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.111B 0.00
ETON PHARMACEUT (ETON) United States $0.110B 0.00
Mersana Therapeutics (MRSN) United States $0.108B 0.00
Cue Biopharma (CUE) United States $0.108B 0.00
Neothetics (EVFM) United States $0.105B 0.00
Spero Therapeutics (SPRO) United States $0.103B 0.00
Eleven Biotherapeutics (SESN) United States $0.101B 0.00
Pluristem Therapeutics (PSTI) Israel $0.101B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Idera Pharmaceuticals (IDRA) United States $0.098B 0.00
NantKwest (NK) United States $0.096B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.093B 103.67
VBI Vaccines (VBIV) United States $0.092B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.092B 0.00
ScPharmaceuticals (SCPH) United States $0.089B 0.00
Anavex Life Sciences (AVXL) United States $0.089B 0.00
Motif Bio Plc (MTFB) United States $0.086B 0.00
Signal Genetics (MGEN) United States $0.083B 0.00
Provention Bio (PRVB) United States $0.083B 0.00
Axsome Therapeutics (AXSM) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.082B 0.00
Chiasma (CHMA) United States $0.081B 0.00
Cel-Sci (CVM) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.077B 0.00
Mustang Bio (MBIO) United States $0.077B 0.00
Cidara Therapeutics (CDTX) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.074B 0.00
VolitionRX (VNRX) Singapore $0.072B 0.00
ITUS (ANIX) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.068B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Bellerophon Therapeutics (BLPH) United States $0.062B 0.00
Monster Digital (INNT) United States $0.061B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
Alcobra (ARCT) United States $0.059B 0.00
BioXcel Therapeutics (BTAI) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.055B 0.00
Evogene (EVGN) Israel $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.054B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
Ophthotech (OPHT) United States $0.052B 0.00
Arsanis (ASNS) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.048B 9.06
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Trevena (TRVN) United States $0.046B 0.00
OncoSec Medical (ONCS) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.044B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
Versartis (ARAV) United States $0.043B 3.79
Aptevo Therapeutics (APVO) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.042B 0.00
Zosano Pharma (ZSAN) United States $0.041B 0.00
Leap Therapeutics (LPTX) United States $0.041B 0.00
Clearside Biomedical (CLSD) United States $0.040B 0.00
Vascular Biogenics (VBLT) Israel $0.039B 0.00
Asterias Biotherapeutics (AST) United States $0.039B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.039B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.038B 0.00
Sophiris Bio (SPHS) United States $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Histogenics (HSGX) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.034B 0.00
Celsion (CLSN) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.032B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
GTx (GTXI) United States $0.028B 0.00
AZURRX BIOPHARM (AZRX) United States $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.026B 4.28
OvaScience (MLND) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
DiaMedica Therapeutics (DMAC) United States $0.025B 0.00
Oragenics (OGEN) United States $0.025B 0.00
BioPharmX (BPMX) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.017B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.016B 8.05
Pulmatrix (PULM) United States $0.016B 0.00
CytRx (CYTR) United States $0.015B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Cellect Biotechnology (APOP) Israel $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
ATyr Pharma (LIFE) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.012B 0.00
Gemphire Therapeutics (GEMP) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Dare Bioscience (DARE) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00